Diaceutics PLC

Full Year 2024 trading results just announced! We are delighted to share a strong performance for FY 2024, reflecting our continued commitment to driving innovation and delivering value for our pharma and biotech partners and the positive outlook moving into 2025. Here are some key highlights, you can view the results in full at: https://lnkd.in/eWG9UmV4 ·  Revenue grows 39% on a constant currency basis to £32.2 million in FY 2024 ·  Order book of £24.9 million and ARR of £16.8 million at 31 December 2024 provides good visibility for continued strong growth in 2025 ·  23% growth in number of customer therapeutic brands working with and three new customer enterprise-wide engagements added in FY 2024 ·  Strong balance sheet with cash of £12.7 million ·  Successfully launched PMx solution and secured first commercial contract as a promotional partner with a leading biotech for the launch of a breakthrough oncology precision medicine in the US ·  New Pathology Engagement Liaison service (PEL) launched and first major customer contract win ·  Increased sales presence in US during FY 2024 and opened US HQ in January 2025 We are excited about the future as we continue to drive innovation in precision medicine and enable more patients to benefit from better treatment. #Diaceutics #PrecisionMedicine #Innovation #Healthcare #Results #FutureFocused #financials

Susanne Munksted, Chief Precision Medicine Officer at Diaceutics, will be speaking at the upcoming Precision Med Tri-Con taking place from the 11-13th March, in San Diego. This event brings together global thought leaders to discuss the latest innovations in precision medicine, diagnostics, and emerging technologies shaping the future of patient care. Don’t miss Susanne’s talk, ‘From exploratory to mainstream; Overcoming access barriers in Liquid Biopsy Testing,’ on Wednesday, 12th March from 10:10-10:40 am. #PMTRICON #PrecisionMedicine 

Join us for our next LabTalk, ‘Variant interpretation in cancer susceptibility genes’ on the 11th March! We are pleased to invite our guest speaker, Dr. Alice Garrett, to host a live webinar that will provide insights into the challenging process of variant interpretation and how The Cancer Variant Interpretation Group UK (CanVIG-UK) is working to improve the consistency of interpretation throughout the clinical setting. Sign up now: https://lnkd.in/eQ3cBPsW 

Don’t miss our next real-world webinar on Monday, March 10, from 12-1 PM EDT / 5-6 PM CET. Scott Phillips, VP of Real-World Data at Diaceutics will discuss how leveraging lab and genetic data can refine precision medicine strategies to help pharma and biotech teams make smarter commercialization decisions. Discover how this approach moves beyond traditional claims aggregation, to overcome market complexities and improve patient outcomes. Register for webinar here: https://lnkd.in/effniHJn #PrecisionMedicine #Webinar #Data

We are ONE WEEK away from the latest release of the Better Testing, Better Treatment podcast! Episode 7: Exploring Inherited Cancer – From Clinic to Lab.  📅 19th February In this episode, we're thrilled to welcome our guests Anna Considine, Consultant Cancer Genetic Counsellor and Samantha Butler, Principal Clinical Scientist, from the Birmingham Women and Children’s NHS Foundation Trust and the West Midlands Regional Genetics Service. Don’t miss this insightful conversation highlighting the importance of collaboration between clinicians and pathologists in driving innovation and improving patient care! You can catch up on all previous episodes of the Better Testing, Better Treatment podcast while you anticipate the next release! https://lnkd.in/ejXD5jTm

Peter Keeling, Founder of Diaceutics, will be speaking at the upcoming "Together is Better - How the Island of Ireland and the US are Collaborating on Cancer Research and Digital Health Innovation" event taking place on 18th March, at the MIT Museum, Boston. Peter will share insights on Diaceutics’ journey from MIT to the forefront of precision medicine and will also join an expert panel discussion alongside industry leaders to explore the latest advancements and opportunities in oncology. This event, hosted in partnership with Cranmore Executive Search, Queen's University Belfast (QUB), University College Dublin (UCD), and the All-Island Cancer Research Institute (AICRI), marks the launch of a major study on the economic potential of oncology and digital health across the island of Ireland. The study highlights the growing strength of the region’s life sciences sector and its expanding global partnerships, particularly with the US. Find out more and register for event here: https://lnkd.in/exuMGpvg #PrecisionMedicine #HealthcareInnovation #CancerHasNoBorders

As the demands of precision medicine grow, the complexity of data can create barriers to success. Join us on Monday, March 10, from 12-1 PM EDT / 5-6 PM CET for our next real-world data webinar, “Complexity to Clarity: Using Multi-Modal Data To Drive Commercial Success.” • Learn how to move beyond stacking data by adopting a multi-modal approach that delivers deeper, actionable insights • Discover how leveraging lab and genetic data can transform your strategies, moving beyond traditional claims aggregation. • Plan for commercial success by identifying opportunities to overcome market challenges and the tactics to deploy    Register for webinar here: https://lnkd.in/effniHJn #PrecisionMedicine #Webinar #DataDriven #BetterTestingBetterTreatment

Don't miss our next real-world data webinar, “Complexity to Clarity: Using Multi-Modal Data To Drive Commercial Success,” Scott Phillips, VP of Real-World Data at Diaceutics, will explore how a multi-modal approach can simplify these challenges and deliver actionable insights.   Join us on Monday, March 10, from 12-1 PM EDT / 5-6 PM CET to learn how leveraging lab and genetic data can refine precision medicine strategies and help pharma and biotech teams make smarter commercialization decisions. Discover how this approach moves beyond traditional claims aggregation to overcome market complexities and improve patient outcomes.   Register for webinar here: https://lnkd.in/effniHJn   #RealWorldData #Webinar #DataDriven

New episode of the Better Testing, Better Treatment podcast coming soon! Episode 7: Exploring Inherited Cancer – From Clinic to Lab. 📅 19th February In episode 7, our guests Anna Considine, Consultant Cancer Genetic Counsellor and Samantha Butler, Principal Clinical Scientist explore how genetic testing for inherited cancer has evolved over the last 20 years, transforming both clinical practice and patient care. Listen as Samantha Butler discusses how the field has shifted, with teams now spending up to 40% of their time on variant interpretation! Tune in to the next episode to hear how advancements in testing are shaping better patient outcomes. You can catch up on previous episodes of the podcast as we wait for the release of episode 7: https://lnkd.in/enFxEKiX

This #WorldCancerDay, we’re highlighting the unique and deeply personal stories that that continue to drive our commitment in advancing precision medicine. Behind every cancer diagnosis is a story of resilience, hope, and determination. At Diaceutics, we’re committed to putting patients at the center of care, ensuring that every patient receives the right treatment at the right time to achieve the best possible outcomes. Swipe through to read these personal stories shared by our team at Diaceutics that remind us why patient-centered care matters, and how we can work together to make a difference. #UnitedByUnique #PrecisionMedicine #PatientStories #WorldCancerDay